Sex-specific effect of AQP9 deficiency on hepatic triglyceride metabolism in mice with diet-induced obesity

被引:3
作者
Elnegaard, Johanne Jul [1 ]
Iena, Francesco Maria [1 ]
Herold, Jacqueline [1 ]
Lebeck, Janne [1 ,2 ]
机构
[1] Aarhus Univ, Dept Biomed, Aarhus, Denmark
[2] Aarhus Univ, Dept Biomed, Wilhelm Meyers 3, DK-8000 Aarhus, Denmark
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2024年 / 602卷 / 13期
关键词
obesity; hepatic steatosis; glycerol; FATTY LIVER-DISEASE; ADIPOSE-TISSUE; GLYCEROL METABOLISM; DOWN-REGULATION; AQUAPORIN-9; EXPRESSION; STEATOSIS; CHANNELS; IMPACT;
D O I
10.1113/JP284188
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Studies in obese rats and human cell models of non-alcoholic fatty liver disease have indicated that knockdown of the hepatic glycerol channel aquaporin 9 (AQP9) leads to decreased hepatic steatosis. However, a study in leptin receptor-deficient mice did not find that knockout (KO) of AQP9 alleviated hepatic steatosis. The aim of this study was to investigate the effect of high-fat diet (HFD) on hepatic glycerol and triglyceride metabolism in male and female AQP9 KO mice. Male and female AQP9 KO mice and wild-type (WT) littermates were fed a HFD for 12 weeks. Weight, food intake and blood glucose were monitored throughout the study and tissue analysis included determination of hepatic triglyceride content and triglyceride secretion. The expression of key molecules for hepatic glycerol and triglyceride metabolism was evaluated using qPCR and western blotting. AQP9 KO and WT mice demonstrated a similar weight gain throughout the study period, and we found no evidence for AQP9 deficiency being associated with a reduced hepatic accumulation of triglyceride or a reduced blood glucose level. Instead, we show that the effect of AQP9 deficiency on hepatic lipid metabolism is sex-specific, with only male AQP9 KO mice having a reduced hepatic secretion of triglycerides and an elevated expression of peroxisome proliferator-activated receptor a. Male AQP9 KO mice had an elevated blood glucose level after 12 weeks of HFD when compared to baseline levels. Thus, we found no evidence for AQP9 inhibition being a target for alleviating the development of hepatic steatosis in mice with diet-induced obesity.
引用
收藏
页码:3131 / 3149
页数:19
相关论文
共 43 条
  • [1] Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
    Balakrishnan, Maya
    Patel, Parth
    Dunn-Valadez, Sydney
    Dao, Cecilia
    Khan, Vinshi
    Ali, Hiba
    El-Serag, Laith
    Hernaez, Ruben
    Sisson, Amy
    Thrift, Aaron P.
    Liu, Yan
    El-Serag, Hashem B.
    Kanwal, Fasiha
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (01) : 61 - +
  • [2] Knockdown of hepatic aquaglyceroporin-9 alleviates high fat diet-induced non-alcoholic fatty liver disease in rats
    Cai, Can
    Wang, Chuan
    Ji, Wen
    Liu, Bo
    Kang, Yujun
    Hu, Zaimin
    Jiang, Zheng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 15 (03) : 550 - 556
  • [3] Biophysical assessment of aquaporin-9 as principal facilitative pathway in mouse liver import of glucogenetic glycerol
    Calamita, Giuseppe
    Gena, Patrizia
    Ferri, Domenico
    Rosito, Anna
    Rojek, Aleksandra
    Nielsen, Soren
    Marinelli, Raul A.
    Fruehbeck, Gema
    Svelto, Maria
    [J]. BIOLOGY OF THE CELL, 2012, 104 (06) : 342 - 351
  • [4] Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver
    Carbrey, JM
    Gorelick-Feldman, DA
    Kozono, D
    Praetorius, J
    Nielsen, S
    Agre, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) : 2945 - 2950
  • [5] Targeted deletion of FATP5 reveals multiple functions in liver metabolism: Alterations in hepatic lipid Homeostasis
    Doege, H
    Baillie, RA
    Ortegon, AM
    Tsang, B
    Wu, QW
    Punreddy, S
    Hirsch, D
    Watson, N
    Gimeno, RE
    Stahl, A
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : 1245 - 1258
  • [6] Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain
    Elkjær, ML
    Vajda, Z
    Nejsum, LN
    Kwon, TH
    Jensen, UB
    Amiry-Moghaddam, M
    Frokiær, J
    Nielsen, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (03) : 1118 - 1128
  • [7] Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease
    Fabbrini, Elisa
    Mohammed, B. Selma
    Magkos, Faidon
    Korenblat, Kevin M.
    Patterson, Bruce W.
    Klein, Samuel
    [J]. GASTROENTEROLOGY, 2008, 134 (02) : 424 - 431
  • [8] Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
    Fabbrini, Elisa
    Magkos, Faidon
    Mohammed, B. Selma
    Pietka, Terri
    Abumrad, Nada A.
    Patterson, Bruce W.
    Okunade, Adewole
    Klein, Samuel
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (36) : 15430 - 15435
  • [9] FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase
    Falcon, Alaric
    Doege, Holger
    Fluitt, Amy
    Tsang, Bernice
    Watson, Nicki
    Kay, Mark A.
    Stahl, Andreas
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2010, 299 (03): : E384 - E393
  • [10] Characterization of the Aquaporin-9 Inhibitor RG100204 In Vitro and in db/db Mice
    Florio, Marilina
    Engfors, Angelica
    Gena, Patrizia
    Larsson, Jessica
    Massaro, Alessandro
    Timpka, Stella
    Reimer, Martina Kvist
    Kjellbom, Per
    Beitz, Eric
    Johanson, Urban
    Ruetzler, Michael
    Calamita, Giuseppe
    [J]. CELLS, 2022, 11 (19)